Clinical Trial Update: Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing concomitant docetaxel with gemcitabine versus sequential therapy (docetaxel followed by gemcitabine) has completed in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Central European Cooperative Oncology Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED